<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03403283</url>
  </required_header>
  <id_info>
    <org_study_id>300000188</org_study_id>
    <secondary_id>5R01EY016077</secondary_id>
    <nct_id>NCT03403283</nct_id>
  </id_info>
  <brief_title>Dyslipidemia and Diabetic Retinopathy</brief_title>
  <acronym>D&amp;D</acronym>
  <official_title>Dyslipidemia and Diabetic Retinopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the reparative cells of blood vessels called
      endothelial progenitor cells(EPC) are defective in people with diabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine if the reparative cells of blood vessels, called
      endothelial progenitor cells (EPC's) are defective in people with diabetes. Diabetic
      retinopathy (DR) is an eye disease related to diabetes. It can cause blurred vision and
      possible bleeding in the blood vessels in the back of the eye (retina). Damage to the cells
      of the blood vessels from DR can cause vision loss or blindness. Even with current
      treatments, the quality of life for people with DR is much reduced.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Increase in acid sphingomyelinase (ASM) expression and activity in bone marrow-derived endothelial progenitor cells (EPCs)</measure>
    <time_frame>3 years</time_frame>
    <description>Peripheral blood of 150 cc, about 8-10 tablespoons will be collected from vein in the arm of both diabetic and control subjects</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Diabetic Retinopathy</condition>
  <condition>Dyslipidemia</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Diabetic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Healthy Controls</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy</intervention_name>
    <arm_group_label>Group 1</arm_group_label>
    <other_name>NPDR - Non Proliferative Diabetic Retinopathy</other_name>
    <other_name>PDR -Proliferative Diabetic Retinopathy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Healthy Controls 15 age matched control subjects</intervention_name>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Ophthalmology and Primary Care Clinics
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any man or woman

          -  Greater than 18 years of age

          -  Diagnosis of diabetes (applies to the Diabetic Arm only) (N=15 Type 1 and N=15 Type

          -  The subject must be willing and have the ability to cooperate with the protocol.
             Children will not be eligible because the investigators need to obtain 150 ml of blood
             and this is in excess of what can be drawn in children.

        Exclusion Criteria:

          -  Female participants must not be pregnant at the time of the blood draw as evident
             through a dipstick pregnancy test.

          -  Have retinal abnormalities other than diabetic retinopathy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria B Grant, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer Moorer</last_name>
    <phone>205 325 8674</phone>
    <email>jmoorer@uabmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maris B Grant, MD, PhD</last_name>
      <phone>317-274-2628</phone>
      <email>mabgrant@iupui.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Moorer</last_name>
      <phone>205 3258674</phone>
      <email>jmoorer@uabmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Maria B Grant, MD, PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2014</study_first_submitted>
  <study_first_submitted_qc>January 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2018</study_first_posted>
  <last_update_submitted>January 11, 2018</last_update_submitted>
  <last_update_submitted_qc>January 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Maria Grant</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

